Literature DB >> 3626785

Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy.

W Wolf, M J Albright, M S Silver, H Weber, U Reichardt, R Sauer.   

Abstract

Fluorine-19 nuclear magnetic resonance allows direct observation of fluorinated drugs and their metabolites in the human body without background signal from the tissue. A well-known fluorinated chemotherapeutic drug, 5-fluorouracil, and its metabolites were observed noninvasively in the liver of three patients undergoing cancer chemotherapy. Spectra were obtained at 1.5 T with a surface coil centered over the right lobe of the patient's liver. Administration of 1.5 gm of 5-fluorouracil was done after positioning in the magnet. Serial spectra, collected over a 2-h period, revealed both the nature of the metabolites present in the liver, and the time course of each patient's metabolism. These observations represent the first noninvasive NMR study of drugs in human patients and show the feasibility of using in vivo F-19 NMR spectroscopy for human studies of fluorinated compounds.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3626785     DOI: 10.1016/0730-725x(87)90016-6

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  20 in total

1.  [Magnetic resonance imaging spectroscopy. Part 1: Basics].

Authors:  P Bachert; L Schröder
Journal:  Radiologe       Date:  2003-12       Impact factor: 0.635

Review 2.  Noninvasive methods to study drug distribution.

Authors:  Ruediger E Port; Walter Wolf
Journal:  Invest New Drugs       Date:  2003-05       Impact factor: 3.850

Review 3.  NMR studies of drug metabolism and disposition.

Authors:  J D Bell; D G Gadian; N E Preece
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 4.  Uses and limitations of nuclear magnetic resonance (NMR) spectroscopy in clinical pharmacokinetics.

Authors:  M C Malet-Martino; R Martino
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

Review 5.  New frontiers and developing applications in 19F NMR.

Authors:  Jian-Xin Yu; Rami R Hallac; Srinivas Chiguru; Ralph P Mason
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2012-11-02       Impact factor: 9.795

Review 6.  Theranostic nanoparticles for cancer and cardiovascular applications.

Authors:  Dan Wang; Bingbing Lin; Hua Ai
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

7.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 8.  In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism.

Authors:  J L Evelhoch
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

9.  Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study.

Authors:  Cary A Presant; Joth Jacobson; Walter Wolf; Victor Waluch; Ilene C Weitz; John S Macdonald
Journal:  Invest New Drugs       Date:  2002-11       Impact factor: 3.850

10.  19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism.

Authors:  M O Fasoli; D Kerridge; P G Morris; A Torosantucci
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.